semaglutide and inflammation Beyond Weight Loss: Exploring the

Food comes first

Diabetes 2009;58:21482161 [DOI] [PMC free article] [PubMed] [Google Scholar] 19.Koehler JA, Drucker DJ

Rosenstock J, Fras JP, Rodbard HW, Tof S, Sears E, Huh R, et al

At least, for now

This subcutaneous angle ensures the medication deposits in the fatty tissue layer beneath the dermis, optimizing absorption and minimizing nerve or blood vessel contact

Responsible virtual GLP-1 care leads to: Higher patient satisfaction and trust Better adherence and persistence with treatment Improved and more sustainable weight loss Stronger metabolic health outcomes Fewer preventable side effects and complications Reduced risk of weight cycling and rebound It also shows up in patient experience